TY - JOUR
T1 - Antimicrobial resistance in organisms causing diarrheal disease
AU - Sack, R. Bradley
AU - Rahman, Mahbubur
AU - Yunus, M.
AU - Khan, Eradul H.
PY - 1997
Y1 - 1997
N2 - Antimicrobial resistance is becoming increasingly important in the treatment of enteric infections, particularly those due to Shigella, Vibrio cholerae, enterotoxigenic Escherichia coli (associated with traveler's diarrhea), and Salmonella typhi. The rate of antimicrobial resistance is highest in the developing world, where the use of antimicrobial drugs is relatively unrestricted. Of greatest immediate concern is the need for an effective, inexpensive antimicrobial that can be used safely as treatment for small children with dysentery due to Shigella, primarily Shigella dysenteriae type 1.
AB - Antimicrobial resistance is becoming increasingly important in the treatment of enteric infections, particularly those due to Shigella, Vibrio cholerae, enterotoxigenic Escherichia coli (associated with traveler's diarrhea), and Salmonella typhi. The rate of antimicrobial resistance is highest in the developing world, where the use of antimicrobial drugs is relatively unrestricted. Of greatest immediate concern is the need for an effective, inexpensive antimicrobial that can be used safely as treatment for small children with dysentery due to Shigella, primarily Shigella dysenteriae type 1.
UR - http://www.scopus.com/inward/record.url?scp=0031031725&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031031725&partnerID=8YFLogxK
U2 - 10.1093/clinids/24.supplement_1.s102
DO - 10.1093/clinids/24.supplement_1.s102
M3 - Article
C2 - 8994788
AN - SCOPUS:0031031725
SN - 1058-4838
VL - 24
SP - S102-S105
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 1 SUPPL.
ER -